| Robin Chin, RPH | |
|
1919 Mineral Spring Ave, North Providence, RI 02904-3772 | |
| (401) 363-2501 | |
| Not Available |
| Full Name | Robin Chin |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1919 Mineral Spring Ave, North Providence, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003404591 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RPH02876 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Robin Chin, RPH 1919 Mineral Spring Ave, North Providence, RI 02904-3772 Ph: (401) 363-2501 | Robin Chin, RPH 1919 Mineral Spring Ave, North Providence, RI 02904-3772 Ph: (401) 363-2501 |
News Archive
This acquisition unifies Medela, a leading brand for breastfeeding solutions, with Bravado, an innovating leader in the nursing apparel category.
Kleiner Perkins Caufield & Byers today announced the doubling of its iFund to $200 million of venture capital for applications for Apple's revolutionary iPhone OS family of products, including iPhone, iPod touch, and iPad. Established in 2008 as a $100 million investment pool, the original iFund is now fully committed across 14 companies.
Watson Pharmaceuticals, Inc., a leading specialty pharmaceutical company, announced today that the United States District Court for the Southern District of Florida has ruled that Watson's generic versions of Mucinex®, Mucinex® D and Mucinex® DM (Guaifenesin, Dextromethorphan HBr/ Guaifenesin, and Pseudoephedrine/Guaifenesin) Extended-Release products, do not infringe U.S. Patent No. 6,372,252.
A study presented today at the International Liver CongressTM 2013 - which evaluated the relationship between non-alcoholic fatty liver disease (NAFLD), early predictors of atherosclerosis and the 10-year Framingham risk score (FRS) - showed that NAFLD increases the risk of early atherosclerotic lesions independent of established cardiovascular (CV) risk factors.
Seven of ten persons with obesity suffer from the serious metabolic complications. Researchers at the Sahlgrenska Academy, University of Gothenburg, Sweden have now been entrusted with the task of leading an international research project to develop methods for identifying which individuals are in the risk zone.
› Verified 2 days ago
Anthony Peter Amato, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1665 Mineral Spring Ave, North Providence, RI 02904 Phone: 401-353-3113 | |
Jeana Depamphilis, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1665 Mineral Spring Ave, North Providence, RI 02904 Phone: 401-353-3113 | |
Lauren Nicole Palmisciano, DOCTOR OF PHARMACY Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 55 Jacksonia Dr, North Providence, RI 02911 Phone: 401-598-6578 | |
Tracy Lombardi, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1510 Smith St, North Providence, RI 02911 Phone: 401-353-3500 | |
Robert Zampini, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1919 Mineral Spring Ave, North Providence, RI 02904 Phone: 401-353-2501 | |
Kevin Silvestre, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 15 Smithfield Rd, North Providence, RI 02904 Phone: 401-353-4075 |